Research report: UCLA researchers receive NIH grant to launch trial for immunotherapy-related diabetes
An NIH-funded phase 1/2 trial will test whether JAK inhibitors can protect pancreatic insulin-producing cells in people who develop diabetes ...
An NIH-funded phase 1/2 trial will test whether JAK inhibitors can protect pancreatic insulin-producing cells in people who develop diabetes ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine